| |
Fatal PE |
No fatal PE |
Dead |
Alive |
| Patients, N |
59 |
7,618 |
212 |
7,465 |
| Clinical characteristics |
| Age >80 years |
17 (29%) |
1,739 (23%) |
85 (40%)‡ |
1,371 (22%) |
| Gender (males) |
26 (44%) |
3,471 (46%) |
92 (43%) |
3,405 (46%) |
| Cancer |
20 (34%)‡ |
1,310 (17%) |
97 (46%)‡ |
1,233 (17%) |
| Chronic heart failure |
11 (19%)* |
775 (10%) |
47 (22%)‡ |
739 (9.9%) |
| Chronic lung disease |
13 (22%) |
1,053 (14%) |
40 (19%)* |
1,026 (14%) |
| Physical examination |
| Heart rate >110 bpm |
24 (41%)‡ |
1,651 (22%) |
69 (33%)‡ |
1,606 (22%) |
| Respiratory rate >30 pm |
4 (40%)‡ |
319 (12%) |
15 (27%)‡ |
308 (12%) |
| SBP levels <100 mm Hg |
16 (27%)‡ |
809 (11%) |
43 (10%)‡ |
782 (11%) |
| Electrocardiogram |
| Atrial fibrillation |
10 (17%)* |
647 (8.5%) |
37 (18%)‡ |
620 (8.3%) |
| Right bundle branch block |
19 (37%)‡ |
1,338 (19%) |
55 (31%)‡ |
1,302 (19%) |
| S1Q3T3pattern |
11 (22%) |
1,410 (20%) |
34 (19%) |
1,387 (20%) |
| Laboratory tests |
| Creatinine levels >1.2 mg/dL |
20 (34%)† |
1,332 (18%) |
64 (30%)‡ |
1,288 (17%) |
| PO2 levels <60 mm Hg (N=5,215) |
28 (70%)† |
2,226 (43%) |
85 (58%)‡ |
2,169 (43%) |
| Sat O2 levels <90% (N=5,438) |
29 (76%)‡ |
1,981 (37%) |
86 (59%)‡ |
1,924 (36%) |
| Echocardiogram |
| Right atrial dilatation |
42 (71%)‡ |
2,226 (29%) |
98 (46%)‡ |
2,170 (29%) |
| RA diameter >5.0 cm (N=207) |
2 (67%)* |
30 (15%) |
2 (25%) |
30 (15%) |
| Visualization of thrombus |
9 (15%)‡ |
163 (2.1%) |
11 (5.2%)† |
161 (2.2%) |
| Rightventriclehypokinesis |
34 (58%)‡ |
1713 (23%) |
77 (36%)‡ |
1670 (22%) |
| PAP levels >35 mm Hg (N=4,649) |
43 (96%)‡ |
3262 (71%) |
127 (88%)‡ |
3178 (71%) |
| RV diameter >3.0 cm (N=1,314) |
6 (86%) |
851 (65%) |
18 (56%) |
839 (65%) |
| TAPSE <1.6 cm (N=1,590) |
3 (60%) |
581 (37%) |
50 (59%)† |
564 (36%) |
|
